Test and treat Covid-19 patients suffering blood-clotting issues
The NHS should institute blood-clotting (coagulation) tests for coronavirus patients admitted to NHS hospitals, to monitor intensively whether patients’ blood clotting response has been seriously harmed by the coronavirus disease and by how much and whether this requires specific targeted treatment to normalise the patient’s blood clotting response?
For those patients whose blood clotting response is found to be abnormal, either generally or in specific organs, such as lungs, kidneys and heart, affecting organ function, treat with appropriate blood-clot busting drugs, such as Tissue Plasminogen Activator (tPA).
https://peterdow.wordpress.com/2020/04/10/coronavirus-new-treatments-trials-and-nhs-best-practice-in-scotland/
For those patients whose blood clotting response is found to be abnormal, either generally or in specific organs, such as lungs, kidneys and heart, affecting organ function, treat with appropriate blood-clot busting drugs, such as Tissue Plasminogen Activator (tPA).
https://peterdow.wordpress.com/2020/04/10/coronavirus-new-treatments-trials-and-nhs-best-practice-in-scotland/
Why the contribution is important
MEDIA HEADLINES
In the medical news,
COVID-19: Could a clot-busting drug help save the lives of patients on ventilators?
in medical science journals,
Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)?: Journal of Trauma and Acute Care Surgery – See also attached PDF
Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series: Journal of Thrombosis and Haemostasis – See also attached PDF
and on American TV News
Deathly Ill Coronavirus Patients Could Be Saved By Heart Attack And Stroke Drug
In the medical news,
COVID-19: Could a clot-busting drug help save the lives of patients on ventilators?
in medical science journals,
Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)?: Journal of Trauma and Acute Care Surgery – See also attached PDF
Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series: Journal of Thrombosis and Haemostasis – See also attached PDF
and on American TV News
Deathly Ill Coronavirus Patients Could Be Saved By Heart Attack And Stroke Drug
by peterdow on May 11, 2020 at 09:54PM
Comments
Log in or register to add comments and rate ideas